mutations, in whom rituximab seems to get small extra value.fifty nine Other genomic subgroups, including people with BIRC3102 On the flip side, quite a few teams are advocating with the incorporation of novel markers, such as a intricate karyotype55 or epigenetic subsets, 27,28 into scientific observe. These novel prognostic and/or predictive vers